| Name & Role | Position | Tenure | Holdings |
|---|---|---|---|
GW PHARMACEUTICALS PLC | U.S. Chief Commercial Officer | Since Apr 2019 | — |
PYXIS ONCOLOGY, INC. | — | Since Oct 2021 | — |
SEAGEN INC. | EVP, Commercial | Since Aug 2018 | — |
STEMLINE THERAPEUTICS INC | — | Since Jun 2019 | — |
PLIANT THERAPEUTICS, INC. | — | Since Mar 2023 | — |
IPI LEGACY LIQUIDATION CO | — | Since Apr 2023 | — |
XENON PHARMACEUTICALS INC. | Chief Commercial Officer | Since Jun 2025 | — |